TMCnet News
Global Diabetic Therapeutic Market 2017-2021: The Strong Potential of Biologics - Leading Players are AstraZeneca, Eli Lilly, Merck, Novo Nordisk & Sanofi - Research and MarketsResearch and Markets has announced the addition of the "Global Diabetic Therapeutic Market 2017-2021" report to their offering. The global diabetic therapeutic market to grow at a CAGR of 7.55% during the period 2017-2021. The global diabetic therapeutic market is growing at a high pace owing to the increase in the prevalence of diabetes globally. The top countries with high prevalence of diabetes are China, India, the US, Brazil, Russia, Mexico, Indonesia, Egypt, Japan, and Bangladesh. It is estimated that more than 1.5 million deaths occur due to diabetes worldwide each year. The report covers the present scenario and the growth prospects of the global diabetic therapeutic market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of branded drugs, generics, and biosimilars used for the treatment of diabetes. The report also considers the revenues to be generated from the sales of drugs that are expected to be launched into the market along with the decline in revenues from the patent expiries of the marketed drugs during the forecast period.. The report covers the market landscape and its growth prospects over te coming years. The report also includes a discussion of the key vendors operating in this market. Market Dynamics Market drivers
Market challenges
Market trends
Key vendors
Key Topics Covered: Part 01: Executive summary Part 02: Scope of the report Part 03: Market research methodology Part 04: Introduction Part 05: Disease overview: Diabetes Part 06: Pipeline portfolio Part 07: Market landscape Part 08: Overview of marketed products Part 09: Market segmentation by type of disease Part 10: Market segmentation by drug class Part 11: Geographical segmentation Part 12: Market drivers Part 13: Impact of drivers Part 14: Market challenges Part 15: Impact of drivers and challenges Part 16: Market trends Part 17: Vendor landscape Part 18: Key vendor analysis Part 19: Appendix For more information about this report visit http://www.researchandmarkets.com/research/rgft9k/global_diabetic
View source version on businesswire.com: http://www.businesswire.com/news/home/20170419006161/en/ |